COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.981
-0.019 (-0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed

COSCIENS Biopharma Statistics

Total Valuation

CSCI has a market cap or net worth of $9.34 million. The enterprise value is -$8.43 million.

Market Cap 9.34M
Enterprise Value -8.43M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

CSCI has 3.12 million shares outstanding. The number of shares has increased by 6.18% in one year.

Current Share Class 3.12M
Shares Outstanding 3.12M
Shares Change (YoY) +6.18%
Shares Change (QoQ) +39.91%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio 0.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.08.

Current Ratio 3.46
Quick Ratio 2.70
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3,624.50

Financial Efficiency

Return on equity (ROE) is -100.27% and return on invested capital (ROIC) is -56.49%.

Return on Equity (ROE) -100.27%
Return on Assets (ROA) -31.52%
Return on Capital (ROIC) -56.49%
Revenue Per Employee $402,833
Profits Per Employee -$1.93M
Employee Count 12
Asset Turnover 0.11
Inventory Turnover 0.39

Taxes

Income Tax -473,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -55.11% in the last 52 weeks. The beta is 2.27, so CSCI's price volatility has been higher than the market average.

Beta (5Y) 2.27
52-Week Price Change -55.11%
50-Day Moving Average 3.68
200-Day Moving Average 6.08
Relative Strength Index (RSI) 31.64
Average Volume (20 Days) 6,805

Short Selling Information

The latest short interest is 5,116, so 0.16% of the outstanding shares have been sold short.

Short Interest 5,116
Short Previous Month 6,774
Short % of Shares Out 0.16%
Short % of Float 0.15%
Short Ratio (days to cover) 1.64

Income Statement

In the last 12 months, CSCI had revenue of $4.83 million and -$23.21 million in losses. Loss per share was -$14.28.

Revenue 4.83M
Gross Profit 4.17M
Operating Income -21.75M
Pretax Income -18.05M
Net Income -23.21M
EBITDA -21.60M
EBIT -21.75M
Loss Per Share -$14.28
Full Income Statement

Balance Sheet

The company has $20.00 million in cash and $1.62 million in debt, giving a net cash position of $18.38 million or $5.89 per share.

Cash & Cash Equivalents 20.00M
Total Debt 1.62M
Net Cash 18.38M
Net Cash Per Share $5.89
Equity (Book Value) 20.01M
Book Value Per Share 6.41
Working Capital 20.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.19 million and capital expenditures -$736,000, giving a free cash flow of -$27.93 million.

Operating Cash Flow -27.19M
Capital Expenditures -736,000
Free Cash Flow -27.93M
FCF Per Share -$8.94
Full Cash Flow Statement

Margins

Gross Margin 86.18%
Operating Margin -449.88%
Pretax Margin -489.90%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -731.63%

Dividends & Yields

CSCI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.18%
Shareholder Yield -6.18%
Earnings Yield -248.39%
FCF Yield -298.88%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25:1.

Last Split Date May 3, 2024
Split Type Reverse
Split Ratio 0.25:1

Scores

CSCI has an Altman Z-Score of -0.85 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.85
Piotroski F-Score 1